{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:51:50Z","timestamp":1777384310752,"version":"3.51.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T00:00:00Z","timestamp":1502236800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"EU Seventh Framework Program, EurAdrenal project","award":["2008-201167"],"award-info":[{"award-number":["2008-201167"]}]},{"name":"ex 60% from the of University of Padua"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s12020-017-1380-8","type":"journal-article","created":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T08:42:13Z","timestamp":1502268133000},"page":"319-329","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison\u2019s disease on glucocorticoid and mineralocorticoid replacement therapy"],"prefix":"10.1007","volume":"59","author":[{"given":"Valentina","family":"Camozzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corrado","family":"Betterle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Chiara","family":"Frigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Zaccariotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Zaninotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"De Caneva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Lucato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Gomiero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Garelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Sabbadin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Salv\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam Dalla","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Boscaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Luisetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,9]]},"reference":[{"key":"1380_CR1","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(03)13492-7","volume":"361","author":"W Arlt","year":"2003","unstructured":"W. Arlt, B. Allolio, Adrenal insufficiency. Lancet 361, 1881\u20131893 (2003)","journal-title":"Lancet"},{"key":"1380_CR2","first-page":"161","volume":"20","author":"C Betterle","year":"2011","unstructured":"C. Betterle, L. Morlin, Autoimmune Addison\u2019s disease. Endocrine. Development 20, 161\u2013172 (2011)","journal-title":"Development"},{"key":"1380_CR3","first-page":"882","volume":"110","author":"M Quinkler","year":"2013","unstructured":"M. Quinkler, F. Beuschlein, S. Hahner, G. Meyer, C. Sch\u00f6fl, G.K. Stalla, Adrenal cortical insufficiency - a life threatening illness with multiple etiologies. Dtsch. Arztebl. Int. 110, 882\u2013888 (2013)","journal-title":"Dtsch. Arztebl. Int."},{"key":"1380_CR4","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1210\/jc.2009-1368","volume":"94","author":"MM Erichsen","year":"2009","unstructured":"M.M. Erichsen, K. Lovas, B. Skinningsrud, A.B. Wolff, D.E. Undlien, J. Svartberg, K.J. Fougner, T.J. Berg, J. Bollerslev, B. Mella, J.A. Carlson, H. Erlich, E.S. Husebye, Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J. Clin. Endocr. Metab. 94, 4882\u20134890 (2009)","journal-title":"J. Clin. Endocr. Metab."},{"key":"1380_CR5","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1530\/EJE-13-0528","volume":"169","author":"C Betterle","year":"2013","unstructured":"C. Betterle, R. Scarpa, S. Garelli, L. Morlin, F. Lazzarotto, F. Presotto, G. Coco, S. Masiero, A. Parolo, M.P. Albergoni, R. Favero, S. Barollo, M. Salv\u00e0, D. Basso, S. Chen, B. Rees Smith, J. Furmaniak, F. Mantero, Addison\u2019s disease: a survey on 633 patients in Padova. Eur. J. Endocrinol. 169, 773\u2013784 (2013)","journal-title":"Eur. J. Endocrinol."},{"key":"1380_CR6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1210\/edrv.23.3.0466","volume":"23","author":"C Betterle","year":"2002","unstructured":"C. Betterle, C. Dal Pra, F. Mantero, R. Zanchetta, Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr. Rev. 23, 327\u2013364 (2002)","journal-title":"Endocr. Rev."},{"key":"1380_CR7","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1056\/NEJMra030158","volume":"13","author":"GS Eisenbarth","year":"2004","unstructured":"G.S. Eisenbarth, P.A. Gottlieb, Autoimmune polyendocrine syndromes. New Engl. J. Med. 13, 2068\u20132079 (2004)","journal-title":"New Engl. J. Med."},{"key":"1380_CR8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-2265.1996.8040813.x","volume":"45","author":"A Soderbergh","year":"1996","unstructured":"A. Soderbergh, O. Winqvist, I. Norheim, F. Rorsman, E.S. Husebye, O. Dolva, F.A. Karlsson, O. K\u00e4mpe, Adrenal autoantibodies and organ-specific autoimmunity in patients with Addison\u2019s disease. Clin. Endocrinol. 45, 453\u2013460 (1996)","journal-title":"Clin. Endocrinol."},{"key":"1380_CR9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12020-010-9312-x","volume":"37","author":"M Fichna","year":"2010","unstructured":"M. Fichna, P. Fichna, M. Gryczynska, J. Walkowiak, M. Zurawek, J. Sowinski, Screening for associated autoimmune disorders in Polish patients with Addison\u2019s disease. Endocrine 37, 349\u2013360 (2010)","journal-title":"Endocrine"},{"key":"1380_CR10","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1210\/jc.2003-030279","volume":"89","author":"A Soderbergh","year":"2004","unstructured":"A. Soderbergh, A.G. Myhre, O. Ekwall, G. Gebre-Medhin, H. Hedstrand, E. Landgren, A. Miettinen, P. Eskelin, M. Halonen, T. Tuomi, J. Gustafsson, E.S. Husebye, J. Perheentupa, M. Gylling, M.P. Manns, F. Rorsman, O. K\u00e4mpe, T. Nilsson, Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. J. Clin. Endocr. Metab. 89, 557\u2013562 (2004)","journal-title":"J. Clin. Endocr. Metab."},{"key":"1380_CR11","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-2796.2009.02090.x","volume":"265","author":"ES Husebye","year":"2009","unstructured":"E.S. Husebye, J. Perheentupa, R. Rautemaa, O. K\u00e4mpe, Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. J. Intern. Med 265, 514\u2013529 (2009)","journal-title":"J. Intern. Med"},{"key":"1380_CR12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.coi.2016.07.003","volume":"6","author":"Oslash Bruserud","year":"2016","unstructured":"\u00d8. Bruserud, B.E. Oftedal, A.B. Wolff, E.S. Husebye, AIRE-mutations and autoimmune disease. Curr. Opin. Immunol. 6, 8\u201315 (2016)","journal-title":"Curr. Opin. Immunol."},{"key":"1380_CR13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/joim.12162","volume":"275","author":"ES Husebye","year":"2014","unstructured":"E.S. Husebye, B. Allolio, W. Arlt, K. Badenhoop, S. Bensing, C. Betterle, A. Falorni, E.H. Gan, A.L. Hulting, A. Kasperlik-Zaluska, O. K\u00e4mpe, K. L\u00f8v\u00e5s, G. Meyer, S.H. Pearce, Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. J. Intern. Med. 275, 104\u2013115 (2014)","journal-title":"J. Intern. Med."},{"key":"1380_CR14","doi-asserted-by":"crossref","first-page":"R165","DOI":"10.1530\/EJE-13-0450","volume":"21","author":"A Grossman","year":"2013","unstructured":"A. Grossman, G. Johannsson, M. Quinkler, P. Zelissen, Therapy of endocrine disease. Perspectives on the management of adrenal insufficiency: clinical insights from across Europe. Eur. J. Endocrinol. 21, R165\u2013R175 (2013)","journal-title":"Eur. J. Endocrinol."},{"key":"1380_CR15","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s12020-012-9835-4","volume":"43","author":"A Falorni","year":"2013","unstructured":"A. Falorni, V. Minarelli, S. Morelli, Therapy of adrenal insufficiency: an update. Endocrine 43, 514\u2013528 (2013)","journal-title":"Endocrine"},{"key":"1380_CR16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/cen.12603","volume":"82","author":"G Johannsson","year":"2015","unstructured":"G. Johannsson, iA. Falorn, S. Skrtic, H. Lennern\u00e4s, M. Quinkler, J.P. Monson, P.M. Stewart, Adrenal insufficiency: review of clinical outcomes with current GC replacement therapy. Clin. Endocrinol. (Oxf.) 82, 2\u201311 (2015)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"1380_CR17","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/bmj.294.6575.798","volume":"294","author":"JP Devogelaer","year":"1987","unstructured":"J.P. Devogelaer, J. Crabb\u00e9; Nagant de Deuxchaisnes, C, Bone mineral density in Addison\u2019s disease: evidence for an effect of adrenal androgens on bone mass. Brit. Med. J. (Clin. Res Ed.) 294, 798\u2013800 (1987)","journal-title":"Brit. Med. J. (Clin. Res Ed.)"},{"key":"1380_CR18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.7326\/0003-4819-120-3-199402010-00005","volume":"120","author":"PM Zelissen","year":"1994","unstructured":"P.M. Zelissen, R.J. Croughs, P.P. van Rijk, J.A. Raymakers, Effect of MC replacement therapy on bone mineral density in patients with Addison disease. Ann. Intern. Med. 120, 207\u2013210 (1994)","journal-title":"Ann. Intern. Med."},{"key":"1380_CR19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0169-6009(08)80158-4","volume":"26","author":"MA Valero","year":"1994","unstructured":"M.A. Valero, M. Leon, M.P. Ruiz Valdepe\u00f1as, L. Larrodera, M.B. Lopez, K. Papapietro, A. Jara, F. Hawkins, Bone density and turnover in Addison\u2019s disease: effect of glucocorticoid treatment. Bone Miner. 26, 9\u201317 (1994)","journal-title":"Bone Miner."},{"key":"1380_CR20","first-page":"179","volume":"61","author":"F Heureux","year":"2000","unstructured":"F. Heureux, D. Maiter, Y. Boutsen, J.P. Devogelaer, J. Jamart, J. Donckier, Evaluation of corticosteroid replacement therapy and its effect on bones in Addison\u2019s disease. Ann. Endocrinol. (Paris) 61, 179\u2013183 (2000)","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"1380_CR21","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1046\/j.1365-2265.2003.01761.x","volume":"58","author":"E J\u00f3dar","year":"2003","unstructured":"E. J\u00f3dar, M.P. Valdepe\u00f1as, G. Martinez, A. Jara, F. Hawkins, Long-term follow-up of bone mineral density in Addison\u2019s disease. Clin. Endocrinol. (Oxf.) 58, 617\u2013620 (2003)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"1380_CR22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1210\/jc.2011-2036","volume":"97","author":"KR Koetz","year":"2012","unstructured":"K.R. Koetz, M. Ventz, S. Diederich, M. Quinkler, Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy. J. Clin. Endocr. Metab. 97, 85\u201392 (2012)","journal-title":"J. Clin. Endocr. Metab."},{"key":"1380_CR23","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4158\/EP151014.OR","volume":"22","author":"DD Chandy","year":"2016","unstructured":"D.D. Chandy, E. Bhatia, Bone mineral density in patients with Addison disease on replacement therapy with prednisolone. Endocr. Pract. 22, 434\u2013439 (2016)","journal-title":"Endocr. Pract."},{"key":"1380_CR24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1530\/EJE-10-0125","volume":"163","author":"G Mazziotti","year":"2010","unstructured":"G. Mazziotti, T. Porcelli, A. Bianchi, V. Cimino, I. Patelli, C. Mejia, A. Fusco, A. Giampietro, L. De Marinis, A. Giustina, Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency. Eur. J. Endocrinol. 163, 15\u201320 (2010)","journal-title":"Eur. J. Endocrinol."},{"key":"1380_CR25","first-page":"1098","volume":"317","author":"RD Mosteller","year":"1987","unstructured":"R.D. Mosteller, Simplified calculation of body surface area. N. Engl. J. Med. 317, 1098 (1987)","journal-title":"N. Engl. J. Med."},{"key":"1380_CR26","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/jbmr.5650110716","volume":"11","author":"HK Genant","year":"1996","unstructured":"H.K. Genant, M. Jergas, L. Palermo, M. Nevitt, R.S. Valentin, D. Black, S.R. Cummings, Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. The study of osteoporotic fractures research group. J. Bone Miner. Res. 11, 984\u2013996 (1996)","journal-title":"J. Bone Miner. Res."},{"key":"1380_CR27","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s00198-005-1891-7","volume":"16","author":"N Binkley","year":"2005","unstructured":"N. Binkley, D. Krueger, R. Gangnon, H.K. Genant, M.K. Drezner, Lateral vertebral assessment: a valuable technique to detect clinically significant vertebral fractures. Osteoporos. Int. 16, 1513\u20138 (2005)","journal-title":"Osteoporos. Int."},{"key":"1380_CR28","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1148\/radiol.2513080887","volume":"251","author":"IC Hospers","year":"2009","unstructured":"I.C. Hospers, J.G. van der Laan, C.J. Zeebregts, P. Nieboer, B.H. Wolffenbuttel, R.A. Dierckx, H.G. Kreeftenberg, P.L. Jager, R.H. Slart, Vertebral fracture assessment in supine position: comparison by using conventional semiquantitative radiography and visual radiography. Radiology 251, 822\u2013828 (2009)","journal-title":"Radiology"},{"key":"1380_CR29","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00198-008-0806-9","volume":"20","author":"T Fuerst","year":"2009","unstructured":"T. Fuerst, C. Wu, H.K. Genant, G. von Ingersleben, Y. Chen, C. Johnston, M.J. Econs, N. Binkley, T.J. Vokes, G. Crans, B.H. Mitlak, Evaluation of vertebral fracture assessment by dual X-ray absorptiometry in a multicenter setting. Osteoporos. Int. 20, 1199\u20131205 (2009)","journal-title":"Osteoporos. Int."},{"key":"1380_CR30","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00198-010-1293-3","volume":"22","author":"PL Jager","year":"2011","unstructured":"P.L. Jager, S. Jonkman, W. Koolhaas, A. Stiekema, B.H. Wolffenbuttel, R.H. Slart, Combined vertebral fracture assessment and bone mineral density measurement: a new standard in the diagnosis of osteoporosis in academic populations. Osteoporos. Int. 22, 1059\u20131068 (2011)","journal-title":"Osteoporos. Int."},{"key":"1380_CR31","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1530\/EJE-08-0880","volume":"160","author":"K L\u00f8v\u00e5s","year":"2009","unstructured":"K. L\u00f8v\u00e5s, C.G. Gjesdal, M. Christensen, A.B. Wolff, B. Alm\u00e5s, J. Svartberg, K.J. Fougner, U. Syversen, J. Bollerslev, J.A. Falch, P.J. Hunt, V.K. Chatterjee, E.S. Husebye, Glucocorticoid replacement therapy and pharmacogenetics in Addison\u2019s disease: effects on bone. Eur. J. Endocrinol. 160, 993\u20131002 (2009)","journal-title":"Eur. J. Endocrinol."},{"key":"1380_CR32","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2796.2011.02352.x","volume":"270","author":"S Bj\u00f6rnsdottir","year":"2011","unstructured":"S. Bj\u00f6rnsdottir, M. S\u00e4\u00e4f, S. Bensing, O. K\u00e4mpe, K. Micha\u00eblsson, J.F. Ludvigsson, Risk of hip fracture in Addison\u2019s disease: a population-based cohort study. J. Intern. Med 270, 187\u2013195 (2011)","journal-title":"J. Intern. Med"},{"key":"1380_CR33","first-page":"179","volume":"61","author":"F Heureux","year":"2000","unstructured":"F. Heureux, D. Maiter, Y. Boutsen, J.P. Devogelaer, Jamar,t J., Donckier J.: evaluation of corticosteroid replacement therapy and its effect on bones in Addison\u2019s disease. Ann. Endocrinol. (Paris) 61, 179\u2013183 (2000)","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"1380_CR34","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1046\/j.1365-2265.2003.01761.x","volume":"58","author":"E J\u00f3dar","year":"2003","unstructured":"E. J\u00f3dar, M.P. Valdepe\u00f1as, G. Martinez, A. Jara, F. Hawkins, Long-term follow-up of bone mineral density in Addison\u2019s disease. Clin. Endocrinol. (Oxf.) 58, 617\u2013620 (2003)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"1380_CR35","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s001980050251","volume":"10","author":"GD Braatvedt","year":"1999","unstructured":"G.D. Braatvedt, M. Joyce, M. Evans, J. Clearwater, I.R. Reid, Bone mineral density in patients with treated Addison\u2019s disease. Osteoporos. Int 10, 435\u2013440 (1999)","journal-title":"Osteoporos. Int"},{"key":"1380_CR36","first-page":"52","volume":"107","author":"CM Florkowski","year":"1994","unstructured":"C.M. Florkowski, S.J. Holmes, J.R. Elliot, R.A. Donald, E.A. Espiner, Bone mineral density is reduced in female but not male subjects with Addison\u2019s disease. N. Z. Med. J. 107, 52\u201353 (1994)","journal-title":"N. Z. Med. J."},{"key":"1380_CR37","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4158\/EP151014.OR","volume":"22","author":"DD Chandy","year":"2016","unstructured":"D.D. Chandy, E. Bhatia, Bone mineral density in patients with Addison\u2019s disease on replacement therapy with prednisolone. Endocr. Pract. 22, 434\u2013439 (2016)","journal-title":"Endocr. Pract."},{"key":"1380_CR38","doi-asserted-by":"crossref","first-page":"207","DOI":"10.7326\/0003-4819-120-3-199402010-00005","volume":"120","author":"PM Zelissen","year":"1994","unstructured":"P.M. Zelissen, R.J. Croughs, P.P. van Rijk, J.A. Raymakers, Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease. Ann. Intern. Med. 120, 207\u2013210 (1994)","journal-title":"Ann. Intern. Med."},{"key":"1380_CR39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1507\/endocrj.51.355","volume":"51","author":"N Chikada","year":"2004","unstructured":"N. Chikada, T. Imaki, M. Hotta, K. Sato, K. Takano, An assessment of bone mineral density in patients with Addison\u2019s disease and isolated ACTH deficiency treated with glucocorticoid. Endocr. J. 51, 355\u2013360 (2004)","journal-title":"Endocr. J."},{"key":"1380_CR40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0169-6009(08)80158-4","volume":"26","author":"MA Valero","year":"1994","unstructured":"M.A. Valero, M. Leon, M.P. Ruiz Valdepe\u00f1as, L. Larrodera, M.B. Lopez, K. Papapietro, A. Jara, F. Hawkins, Bone density and turnover in Addison\u2019s disease: effect of glucocorticoid treatment. Bone Miner. 26, 9\u201317 (1994)","journal-title":"Bone Miner."},{"key":"1380_CR41","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1530\/EJE-13-0596","volume":"170","author":"LA Behan","year":"2013","unstructured":"L.A. Behan, G. Kelleher, M.J. Hannon, J.J. Brady, B. Rogers, W. Tormey, D. Smith, C.J. Thompson, M.J. McKenna, A. Agha, Low-dose hydrocortisone replacement therapy is associated with improved bone remodelling balance in hypopituitary male patients. Eur. J. Endocrinol. 170, 141\u2013150 (2013)","journal-title":"Eur. J. Endocrinol."},{"key":"1380_CR42","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1530\/EJE-15-1096","volume":"174","author":"J Schulz","year":"2016","unstructured":"J. Schulz, K.R. Frey, M.S. Cooper, K. Zopf, M. Ventz, S. Diederich, M. Quinkler, Reduction in daily hydrocortisone dose improves bone health in primary adrenal insufficiency. Eur. J. Endocrinol. 174, 531\u2013538 (2016)","journal-title":"Eur. J. Endocrinol."},{"key":"1380_CR43","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.tem.2006.03.009","volume":"7","author":"G Mazziotti","year":"2006","unstructured":"G. Mazziotti, A. Angeli, J.P. Bilezikian, E. Canalis, A. Giustina, Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol. Metab. 7, 144\u2013149 (2006)","journal-title":"Trends Endocrinol. Metab."},{"key":"1380_CR44","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000184942","volume":"48","author":"FP Cappuccio","year":"1988","unstructured":"F.P. Cappuccio, N.D. Markandu, G.A. MacGregor, Renal handling of calcium and phosphate during mineralocorticoid administration in normal subjects. Nephron 48, 280\u2013283 (1988)","journal-title":"Nephron"},{"key":"1380_CR45","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1152\/ajplegacy.1968.215.1.71","volume":"215","author":"WN Suki","year":"1968","unstructured":"W.N. Suki, R.S. Schwettmann, F.C. Rector Jr, D.W. Seldin, Effect of chronic mineralocorticoid administration on calcium excretion in the rat. Am. J. Physiol. 215, 71\u201374 (1968)","journal-title":"Am. J. Physiol."},{"key":"1380_CR46","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/0895-7061(95)00182-O","volume":"8","author":"E Rossi","year":"1995","unstructured":"E. Rossi, C. Sani, F. Perazzoli, M.C. Casoli, A. Negro, C. Dotti, Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas. Am. J. Hypertens. 8, 884\u2013893 (1995)","journal-title":"Am. J. Hypertens."},{"key":"1380_CR47","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1007\/s00198-013-2399-1","volume":"24","author":"L Ceccoli","year":"2013","unstructured":"L. Ceccoli, V. Ronconi, L. Giovannini, M. Marcheggiani, F. Turchi, M. Boscaro, G. Giacchetti, Bone health and aldosterone excess. Osteoporos. Int. 24, 2801\u20132807 (2013)","journal-title":"Osteoporos. Int."},{"key":"1380_CR48","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/836529","author":"L Petramala","year":"2014","unstructured":"L.Petramala, L.Zinnamosca, A.Settevendemmie, C.Marinelli, M.Nardi, A.Concistr\u00e8, F.Corpaci, G.Tonnarini, G.De Toma, C.Letizia Bone and Mineral metabolism in patients with primary aldosteronism.Int. J. Endocrinol (2014). doi:10.1155\/2014\/836529","journal-title":"Int. J. Endocrinol"},{"key":"1380_CR49","first-page":"14625","volume":"8","author":"Y Zhang","year":"2015","unstructured":"Y. Zhang, B. Feng, Association of serum parathyrine and calcium levels with primary aldosteronism: a meta-analysis. Int. J. Clin. Exp. Med. 8, 14625\u201314633 (2015)","journal-title":"Int. J. Clin. Exp. Med."},{"key":"1380_CR50","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1359\/jbmr.2001.16.8.1496","volume":"16","author":"S Beavan","year":"2001","unstructured":"S. Beavan, A. Horner, S. Bord, D. Ireland, J. Compston, Colocalization of glucocorticoid and mineralocorticoid receptors in human bone. J. Bone Miner. Res. 16, 1496\u20131504 (2001)","journal-title":"J. Bone Miner. Res."},{"key":"1380_CR51","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.1128\/MCB.00253-07","volume":"27","author":"NZ Lu","year":"2007","unstructured":"N.Z. Lu, J.B. Collins, S.F. Grissom, J.A. Cidlowski, Selective regulation of bone cell apoptosis by translational isoforms of the glucocorticoid receptor. Mol. Cell Biol. 27, 7143\u20137160 (2007)","journal-title":"Mol. Cell Biol."},{"key":"1380_CR52","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.2174\/138161210793797924","volume":"16","author":"R Corte La","year":"2010","unstructured":"R. La Corte, F. Trotta, S. Adami, Glucocorticoid receptors and bone. Curr. Pharm. Des. 16, 3586\u20133592 (2010)","journal-title":"Curr. Pharm. Des."},{"key":"1380_CR53","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1210\/me.2011-1116","volume":"26","author":"CM Jewell","year":"2012","unstructured":"C.M. Jewell, A.B. Scoltock, B.L. Hamel, M.R. Yudt, J.A. Cidlowski, Complex human glucocorticoid receptor dim mutations define glucocorticoid-induced apoptotic resistance in bone cells. Mol. Endocrinol. 26, 244\u2013256 (2012)","journal-title":"Mol. Endocrinol."},{"key":"1380_CR54","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.molmed.2012.04.005","volume":"18","author":"P Moutsatsou","year":"2012","unstructured":"P. Moutsatsou, E. Kassi, A.G. Papavassiliou, Glucocorticoid receptor signaling in bone cells. Trends Mol. Med. 18, 348\u2013359 (2012)","journal-title":"Trends Mol. Med."},{"key":"1380_CR55","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bone.2016.08.024","volume":"93","author":"HH Conaway","year":"2016","unstructured":"H.H. Conaway, P. Henning, A. Lie, J. Tuckermann, U.H. Lerner, Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL-induced mature osteoclast bone resorbing activity. Bone 93, 43\u201354 (2016)","journal-title":"Bone"},{"key":"1380_CR56","doi-asserted-by":"crossref","first-page":"C1088","DOI":"10.1152\/ajpcell.1996.270.4.C1088","volume":"270","author":"MK Agarwal","year":"1996","unstructured":"M.K. Agarwal, F. Mirshahi, M. Mirshahi, S. Bracq, J. Chentoufi, M. Hott, A. Jullienne, P.J. Marie, Evidence for receptor-mediated mineralocorticoid action in rat osteoblastic cells. Am. J. Physiol. 270, C1088\u2013C1095 (1996)","journal-title":"Am. J. Physiol."},{"key":"1380_CR57","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.bbrc.2014.03.149","volume":"447","author":"T Fumoto","year":"2014","unstructured":"T. Fumoto, K.A. Ishii, M. Ito, S. Berger, G. Sch\u00fctz, K. Ikeda, Mineralocorticoid receptor function in bone metabolism and its role in glucocorticoid-induced osteopenia. Biochem. Biophys. Res. Commun. 447, 407\u2013412 (2014)","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1380_CR58","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1210\/jcem.87.6.8557","volume":"87","author":"KK Miller","year":"2002","unstructured":"K.K. Miller, B.M. Biller, J. Hier, E. Arena, A. Klibanski, Androgens and bone density in women with hypopituitarism. J. Clin. Endocr. Metab. 87, 2770\u20132776 (2002)","journal-title":"J. Clin. Endocr. Metab."},{"key":"1380_CR59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2005.02.050","volume":"330","author":"LJ Dominguez","year":"2005","unstructured":"L.J. Dominguez, M. Barbagallo, L. Moro, Collagen overglycosylation: a biochemical feature that may contribute to bone quality. Biochem. Biophys. Res. Commun. 330, 1\u20134 (2005)","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1380_CR60","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1056\/NEJMra053077","volume":"354","author":"E Seeman","year":"2006","unstructured":"E. Seeman, P.D. Delmas, Bone quality - the material and structural basis of bone strength and fragility. N. Engl. J. Med. 354, 2250\u20132261 (2006)","journal-title":"N. Engl. J. Med."},{"key":"1380_CR61","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","volume":"18","author":"E Canalis","year":"2007","unstructured":"E. Canalis, G. Mazziotti, A. Giustina, J.P. Bilezikian, Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos. Int. 18, 1319\u20131328 (2007)","journal-title":"Osteoporos. Int."},{"key":"1380_CR62","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrendo.2013.5","volume":"9","author":"G Mazziotti","year":"2013","unstructured":"G. Mazziotti, A. Giustina, Glucocorticoids and the regulation of growth hormone secretion. Nat. Rev. Endocrinol. 9, 265\u2013276 (2013)","journal-title":"Nat. Rev. Endocrinol."},{"key":"1380_CR63","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1471-0528.2012.03324.x","volume":"119","author":"O Svejme","year":"2012","unstructured":"O. Svejme, H.G. Ahlborg, J.\u00c5. Nilsson, M.K. Karlsson, Early menopause and risk of osteoporosis, fracture and mortality: a 34-year prospective observational study in 390 women. Br. J. Obstet. Gynaecol. 119, 810\u2013816 (2012)","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"1380_CR64","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/dme.12734","volume":"32","author":"VN Shah","year":"2015","unstructured":"V.N. Shah, C.S. Shah, J.K. Snell-Bergeon, Type 1 diabetes and risk of fracture: meta-analysis and review of the literature. Diabet. Med. 32, 1134\u20131142 (2015)","journal-title":"Diabet. Med."},{"key":"1380_CR65","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jdiacomp.2015.05.007","volume":"29","author":"W Rathmann","year":"2015","unstructured":"W. Rathmann, K. Kostev, Fracture risk in patients with newly diagnosed type 2 diabetes: a retrospective database analysis in primary care. J. Diabetes Complicat. 29, 766\u2013770 (2015)","journal-title":"J. Diabetes Complicat."},{"key":"1380_CR66","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/MED.0b013e328340533d","volume":"17","author":"DL Kamen","year":"2010","unstructured":"D.L. Kamen, J.D. Alele, Skeletal manifestations of systemic autoimmune diseases. Curr. Opin. Endocrinol. Diabetes Obes. 17, 540\u2013545 (2010)","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"1380_CR67","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.bone.2009.09.034","volume":"46","author":"F Lombardi","year":"2010","unstructured":"F. Lombardi, A. Franzese, D. Iafusco, A. del Puente, A. Esposito, F. Prisco, R. Troncone, G. Valerio, Bone involvement in clusters of autoimmune diseases: just a complication? Bone 46, 551\u2013555 (2010)","journal-title":"Bone"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-017-1380-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1380-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1380-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T01:19:06Z","timestamp":1569979146000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-017-1380-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,9]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["1380"],"URL":"https:\/\/doi.org\/10.1007\/s12020-017-1380-8","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,9]]}}}